Brand-name drug prices rising at a slower pace

According to an Associated Press analysis, it found drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to. The AP found in the first seven months of 2019, drugmakers raised list prices for brand-name prescription medicines by a median of five percent which is down from about nine percent or 10 percent over those months the prior four years. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.